| Article
Primary care clinicians need to be very careful about dosing methadone for all sorts of reasons. Most importantly they need to worry about drug interactions and dosing, converting a patient from morphine or an equivalent dose of another opioid to methadone. Even if we could determine what an exact...
| Article
With acetaminophen, the most important thing to think about is liver toxicity, and remembering to take age into account when you’re thinking about the maximum dosing. And it’s important to be sure that patients are aware that there are a lot of agents out there that have acetaminophen as an...
| Video
An epidemiologist looks at opioid therapy from the perspective of dose vs risk relationships, and comments on how communities can better harness local initiative and interest to combat overdose events.
| Video
Drs. Carter and Schatman consider the consequences that would accrue from the removal of opioids from the therapeutic options for chronic pain. The segment also discusses the characteristics of a “better” opioid, and the research understanding needed to get there.
| Video
Drs. Carter and Schatman consider the consequences that would accrue from the removal of opioids from the therapeutic options for chronic pain. The segment also discusses the characteristics of a “better” opioid, and the research understanding needed to get there.
| Video
Some further observations on the role of opioids, including advice to the primary clinician as they approach the prescribing decision.
| Video
Dr. Argoff comments on the appropriate role of opioid analgesics as part of therapy for chronic noncancer pain, with observations on protecting legitimate access while preventing abuse.
| Article
I think the important thing with methadone is safety first. Even though I’m a big methadone fan, I don’t think everyone is an ideal candidate for methadone therapy. I think we have to have a patient who’s very reliable, who will follow the plan of care, who will follow the directions, someone who...
| Video
What would the world be like without opioids? Dr. Clark hypothesizes on the implications for patients with pain, and on what the characteristics of a “better” opioid might include.
| Video
In this 2-part segment, Dr. Passik discusses some of the lessons learned during and following the Decade of Pain Control and Research, and implications for the appropriate engagement of opioid therapy in chronic noncancer pain management.